Back to my company list

Quibim

The AI engine Fit Assessment

Beta

Quibim is a leader in medical imaging analysis, utilizing AI to enhance the detection of diseases and track treatment efficacy through quantitative imaging biomarkers. Their platform integrates multi-omics data and advanced algorithms to improve patient outcomes in various medical fields, including oncology and immunology.

Blurb

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

HQ Location

Valencia (Spain)

Founded

2012

Employees

51 - 200

Total funding raised

$69.59M

Last Funding Event

Series A, $50.00M, January 28, 2025

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Biomarker Identification

Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading pharmaceutical companies and research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of novel treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. We understand every body part. We speak human.